ValiRx plc (LON:VAL – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.11 ($0.01) and traded as low as GBX 0.52 ($0.01). ValiRx shares last traded at GBX 0.54 ($0.01), with a volume of 2,136,314 shares changing hands.
ValiRx Stock Performance
The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of £2.03 million, a price-to-earnings ratio of -0.36 and a beta of 0.59. The stock’s 50 day moving average is GBX 0.67 and its two-hundred day moving average is GBX 1.11.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Investing in Commodities: What Are They? How to Invest in Them
- MarketBeat Week in Review – 03/24 – 03/28
- Using the MarketBeat Dividend Tax Calculator
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Business Services Stocks Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
